IGF-1 LR3 is the primary protein involved in responses of cells to growth hormone (GH): that is, IGF-I is produced in response to GH and then induces cellular activities
By understanding its relationship with other IGF-1 isoforms like MGF, its systemic effects, and its regenerative potential, researchers and practitioners can better appreciate its role in performance, recovery, and longevity optimization.
Peptides are normally administered by subcutaneous injection, and so it goes with tesamorelin
Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route Frontiers in Endocrinology Growth hormone secretagogues: history and clinical applications Endocrine Reviews Ghrelin and growth hormone secretagogues: physiology and applications Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides